Physician profile
Shama Rasheed
NPI 1417937350
$1,263.52
in general payments reported to CMS, 2019-2025
16 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $64.72 · 2021: $70.05 · 2022: $102 · 2023: $118 · 2024: $169 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $269.21 | 2025 | Caplyta |
| Alkermes, INC. | $226.58 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $140.88 | 2019 | |
| Curonix LLC | $130.39 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Axsome Therapeutics, INC. | $117.65 | 2023 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $107.14 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $69.53 | 2019 | |
| Medtronic, INC. | $38.96 | 2024 | Intellis Adaptivestim |
| Adlon Therapeutics L.P. | $37.36 | 2019-2020 | |
| Shire North American Group INC | $25.59 | 2019 | |
| Neurocrine Biosciences, INC. | $23.03 | 2020 | |
| Bausch Health US, LLC | $19.52 | 2021 | |
| Ironshore Pharmaceuticals INC. | $17.28 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.41 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.02 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Owp Pharmaceuticals, INC. | $9.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shama Rasheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.